K279-1175 Screening compound: 2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-CYCLOHEXYLACETAMIDE

K279-1175 Screening compound: 2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-CYCLOHEXYLACETAMIDE
K279-1175 Screening compound: 2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-CYCLOHEXYLACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1175
2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-CYCLOHEXYLACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1175

Molecular Formula

C27H25ClN6O3S (C27 H25 ClN6 O3 S)

Compound Name

2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-CYCLOHEXYLACETAMIDE

IUPAC name

n/a

SMILES

O=C(CC1N2C(SCC(N=C(C=C3)N4C=C3Cl)=CC4=O)=Nc(cccc3)c3C2=NC1=O)NC1CCCCC1

InChI

InChI=1S/C27H25ClN6O3S/c28-16-10-11-22-29-18(12-24(36)33(22)14-16)15-38-27-31-20-9-5-4-8-19(20)25-32-26(37)21(34(25)27)13-23(35)30-17-6-2-1-3-7-17/h4-5,8-12,14,17,21H,1-3,6-7,13,15H2,(H,30,35)/t21-/m0/s1

InChI Key

ZCWRTHPBSFDDBE-NRFANRHFSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

549.05

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.530

Distribution Coefficient, logD

2.529

Water Solubility, LogSw

-3.58

Polar Surface Area

85.854

Acid Dissociation Constant (pKa)

11.05

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

K279-1175 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with K279-1175 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1175?
Check Price and Availability of K279-1175, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1175 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1175
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1175
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1175 available by request